Older Adults (65 Years and Older)VR-C-REHABNCT07459439
Feasibility of Virtual Reality-assisted Ergometer Cycling in Addition to Regular Rehabilitation During Municipality-based Inpatient Rehabilitation Care
A study testing VR cycling in people with Older Adults (65 Years and Older) and Outpatient Treatment, run by Horsholm Municipality at 2 sites in Denmark.
Trial summary
VR-C-REHAB is a single-group pilot and feasibility study examining the practicality of implementing virtual-reality-assisted ergometer cycling as an adjunct to usual municipal inpatient rehabilitation for older adults (≥65 years). Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Older Adults (65 Years and Older), Outpatient Treatment, Rehabilitation Frail Elderly Subjects
- What is being tested?
- VR cycling
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 12 participants
- Where
- 2 sitesDenmark
- Study dates
- 9 Mar 2026to 18 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Age ≥65 years
- Referred to rehabilitation during a stay at temporary inpatient care
- Assessed by a therapist as capable of participating in seated cycling (possibly supervised)
- Able to provide informed consent (with relevant support according to local guidelines, if necessary).
Who cannot join
- Medical contraindications to moderate physical activity/cycling (e.g., unstable angina, uncontrolled arrhythmia, acute infection with significant impact)
- Severe dizziness/vestibular symptoms likely to be exacerbated by VR use
- Known photosensitive epilepsy or other conditions posing significant risk with VR stimulation
- Unresolved vision/perception issues or severe nausea rendering VR use unsuitable
- Participation in another intervention study that interferes with this intervention.
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites
Bispebjerg Hospital
Copenhagen
Sundheds- og rehabiliteringscenter Hørsholm
Hørsholm, 2970
About this study
Official title: Feasibility of Virtual Reality-assisted Ergometer Cycling in Addition to Regular Rehabilitation During Municipality-based Inpatient Rehabilitation Care: A Single-group Pilot- and Feasibility-trial - VR-C-Rehab
VR-C-REHAB is a single-group pilot and feasibility study examining the practicality of implementing virtual-reality-assisted ergometer cycling as an adjunct to usual municipal inpatient rehabilitation for older adults (≥65 years). Many individuals admitted to temporary inpatient care present with low physical activity levels and fluctuating motivation, reducing the achievable exercise dose. Virtual reality may enhance engagement, enjoyment, and adherence, but its feasibility in this setting must be evaluated before conducting a future effect trial.
The primary objective is to determine whether participants can achieve an adequate exercise dose, defined as the proportion of completed VR-cycling sessions out of those offered (target: ≥75%). Secondary feasibility outcomes include recruitment rate, safety and acceptability, and total cycling time. Exploratory outcomes include change in the 10-Meter Walk Test and session-level motivation (0-10). The intervention consists of 15 minutes of VR-assisted cycling, three times weekly for up to four weeks, delivered alongside standard rehabilitation.
Data are collected at baseline, during each session, and at completion. Analyses are descriptive, focusing on the precision of feasibility estimates. Progression criteria (Go/Amend/Stop) are based on adherence, recruitment, and safety. The results will inform the design and implementation of a subsequent controlled study.
Read the detailed description
Background and Rationale:
Elderly individuals with diminished physical capacity who are admitted to temporary inpatient rehabilitation often exhibit low levels of physical activity and motivation, which can adversely affect the exercise dose during their stay. Cycling is recognized as a safe and effective form of exercise; however, its implementation is often hindered by low commitment and fluctuating daily energy levels.
Virtual reality (VR) has the potential to enhance motivation, perceived enjoyment, and adherence to training by providing distraction, engagement, and a more stimulating exercise environment. Prior to conducting a potential impact study, it is essential to assess the feasibility of recruitment, implementation, acceptance, and exercise dose within municipal inpatient rehabilitation settings.
Objective and Research Question:
Overall Objective:
To investigate the feasibility of a VR-assisted ergometer cycling intervention in conjunction with standard treatment for older adults (aged 65 and above) in rehabilitation during municipality-based inpatient rehabilitation care.
Primary Feasibility Question:
Can participants achieve an adequate exercise dose, as measured by the proportion of completed VR-assisted ergometer cycling sessions out of the total offered sessions, with a feasibility target of ≥75%?
Secondary Feasibility and Exploratory Questions:
What is the recruitment rate (percent proportion of approached individuals who consent to participate)? How does the 10-Meter Walk Test (10 MWT) progress from baseline to completion, reported in m/s? Motivation, Scale 0-10, 10 indicate the highest degree of motivation What is the total duration of cycling (in minutes) completed during the intervention period?
Setting:
Location: Municipality-based inpatient rehabilitation care in the municipality of Hørsholm, managed by the municipal rehabilitation unit.
Regular Treatment: Standard rehabilitation, typically comprising individual and/or group-based training, activities of daily living (ADL) interventions, and mobilization following clinical assessment.
Intervention:
Overview:
Intervention: 15 minutes of cycling with VR goggles in addition to regular treatment.
Frequency: Three times weekly. Duration: Up to 4 weeks (dependent on discharge timing). Delivery: Supervised by physiotherapists or therapeutic staff according to local practices.
Implementation:
Bicycle: Stationary bicycle/ergometer cycle [insert model]. VR Equipment: SyncSense.
Session Structure:
Brief health check (e.g., assessment of tiredness, dizziness, nausea, pain, blood pressure/pulse if relevant) Setup of VR and safe positioning 15 minutes of cycling (pauses permitted) brief conclusion and documentation of any discomfort/side effects.
Dosage and Progression:
The approach is "pragmatic" feasibility, with intensity adjusted to daily energy levels.
The therapist may modify the load (resistance) and pauses to facilitate completion.
Simultaneous Treatment:
Regular rehabilitation continues unchanged and is documented in general terms (e.g., number of therapy contacts per week, if feasible).
Sample Size (Pilot/Feasibility Rationale) A power calculation for the effect will not be conducted. The sample size is determined to estimate feasibility parameters with reasonable precision.
Planned inclusion is N = [12-20] participants. The rationale is to estimate adherence and recruitment rates with confidence intervals and to identify practical implementation barriers.
Recruitment and Consent Screening: Conducted daily/weekly through admission lists/referrals to inpatient care.
Recruitment Procedure:
Involves the identification of potentially suitable individuals Provision of verbal and written information Reflection time in accordance with local guidelines Collection of informed consent A log will cover the number screened, eligible, approached, consented, and causes for dropout/"no".
Statistics and Analysis Plan
General Principle:
The primary descriptive analysis will focus on feasibility estimates and precision, specifically confidence intervals.
No formal hypothesis testing for effect will be conducted; secondary outcomes will be reported in an exploratory manner.
Primary Outcome
Adherence will be reported as follows:
Percent of offered sessions completed. Up to 4 weeks (from baseline to discharge or week 4, whichever occurs first Average (SD) and median (IQR) per participant Collective share of completed/offered sessions for the cohort Recruitment Rate Proportion in percent; Percent consented among approached Causes for non-participation will be categorized. 10MWT and Bicycle Time Change from baseline to finish will be reported as mean change (SD) or median change (IQR).
Visualization: individual spaghetti plots for 10MWT. Lack of Data Feasibility will be assessed by registering the cause of missing measurements (e.g., discharge, illness, logistics).
No imputation will be performed as a general rule; transparency in reporting will be maintained.
Bias and Assurance of Quality Standardized instruction for 10MWT will be provided. Staff will be trained in setting up VR and ensuring safety. Predefined criteria for "offered session" versus "not offered" will be documented, including staff- and illness-related causes.
Injury and Adverse Events All VR-related discomforts (e.g., nausea, dizziness) will be registered. Severe incidents will be reported following local procedures. Stop criteria per session include significant dizziness, nausea, chest pain, acute deterioration, or therapeutic assessment.
Data Management and Security All physical documents, including training records, test results, and the identification key (linking participant IDs to personal information), will be stored in a double-locked cabinet at the primary project site. Access is restricted to authorized project personnel.
Electronic data for statistical analysis will be entered into a secure, encrypted network folder within the municipality's protected IT infrastructure. These datasets will be maintained in an anonymized format, where participants are identified solely by a project-specific ID. No personally identifiable information will appear in the electronic dataset.
The identification key will remain exclusively in paper format and will be stored in the same double-locked cabinet as the physical training and testing data. This key will not be digitized and will only be accessed by the principal investigator or designated personnel for validation or follow-up purposes.
All data handling complies with GDPR regulations and principles for secure management of sensitive personal information. Data will be retained for five years after project completion, after which it will be securely destroyed or archived according to ethical and legal requirements.
The project has been declared to the local ethics committee of the capital region, Denmark, and has received identification number: F-26001623
Communication Results will be reported in accordance with CONSORT pilot/feasibility guidelines, including a flowchart and clear separation between feasibility results and exploratory effect indicators.
Plan: conference abstract and manuscript in a relevant rehabilitation/geriatric journal.
- Conditions
- Older Adults (65 Years and Older), Outpatient Treatment, Rehabilitation Frail Elderly Subjects
- Being tested
- VR cycling
- Keywords
- municipality-based inpatient rehabilitation care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VR cyclingOther
- Intervention: 15 minutes of cycling with VR goggles in addition to regular treatment.
- Frequency: Three times weekly.
- Duration: Up to 4 weeks (dependent on discharge timing).
- Delivery: Supervised by physiotherapists or therapeutic staff according to local practices.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Not described Receives: Other: VR cycling |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise Adherence: In percent
Definition: NumbercompletedVR-bicyclessessions/ NumberofferedVR-bicyclesessioner pr. participant, summarised and/or averaged for the entire cohort.
The feasibility goal is set at ≥75%. "Offered sessions" are defined as the planned three weekly sessions during the period the participant is admitted and available, excluding days with clearly documented contraindications or acute illness according to predetermined criteria. The reasons for lack of training will be explicitly described in the manual as "illness," covering biological illness or other admitted causes, and "demotivation," which encompasses reasons such as tiredness, demotivation, or discomfort. The actual cause will be described.
Measured: 4 weeks (at every exercise session)
Secondary outcomes (4)
1. Recruitment Rate: Percent
Definition: number whoconsent/ number asked,
Measured: Baseline testing (day 0)
walk speed
10MWT: M/s
- The time it takes the patient to walk 10 meters with a standing start, using walking aid if needed Measurements are taken at baseline (before the first session) and at completion (at discharge or week 4), converted to m/s.
Measured: baseline testing and follow up testing after ending the intervention( up to 4 weeks later)
Motivation
Motivation: 0-10, 10 indicate highest degree of motivation
- Assessed by measuring the participant's motivation on a 0-10 scale at the start of each exercise session, recorded at the start of every session.
Measured: during every session from enrollment until end of intervention (max 4 weeks)
Total Time Spent Cycling in minutes
Total Time Spent Cycling: Minutes
- Defined as the total bicycle time (minutes) completed with VR during the study period, calculated as the sum of minutes per session.
Measured: Week 4 (or after conclusion of the intervention if that happens before)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2026
- Study start9 Mar 2026
- Primary completion6 Jun 2026
- Study completion18 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Older Adults (65 Years and Older)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- interventional study with allocation: N/A, masking: none/open label
- Masking
- None (open label)
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Horsholm Municipality
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Niklas Grundt Hansen, Horsholm Municipality
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07459439
- Sponsor's protocol ID
- VR-C-REHAB
- Acronym
- VR-C-REHAB
- Status last verified
- Jun 2026
- First submitted
- 1 Mar 2026
- Last updated
- 26 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymized data on all outcomes will be provided upon request during or after a publication proces.
Publications
Mocco A, Valmaggia L, Bernardi L, Alfieri M, Tarricone I. Enhancing Physical Activity with Immersive Virtual Reality: A Systematic Review. Cyberpsychol Behav Soc Netw. 2024 May;27(5):303-317. doi: 10.1089/cyber.2023.0394. Epub 2024 Mar 20.
PubMed 38506442Hajder D, Bjelica B, Bubanj S, Aksovic N, Markovic M, Arsenijevic R, Lupu GS, Gasic T, Sufaru C, Toskic L, Dobreci DL, Dobrescu T, Sava MA. A Systematic Review and Meta-Analysis of Virtual and Traditional Physical Activity Programs: Effects on Physical, Health, and Cognitive Outcomes. Healthcare (Basel). 2025 Mar 24;13(7):711. doi: 10.3390/healthcare13070711.
PubMed 40218010Rytterstrom P, Stromberg A, Jaarsma T, Klompstra L. Exergaming to Increase Physical Activity in Older Adults: Feasibility and Practical Implications. Curr Heart Fail Rep. 2024 Aug;21(4):439-459. doi: 10.1007/s11897-024-00675-9. Epub 2024 Jul 18.
PubMed 39023808Campo-Prieto P, Cancela-Carral JM, Rodriguez-Fuentes G. Feasibility and Effects of an Immersive Virtual Reality Exergame Program on Physical Functions in Institutionalized Older Adults: A Randomized Clinical Trial. Sensors (Basel). 2022 Sep 6;22(18):6742. doi: 10.3390/s22186742.
PubMed 36146092
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility of Virtual Reality-assisted Ergometer Cycling in Addition to Regular Rehabilitation During Municipality-based Inpatient Rehabilitation Care: A Single-group Pilot- and Feasibility-trial - VR-C-Rehab
- ClinicalTrials.gov ID
- NCT07459439
- Acronym / sponsor ID
- VR-C-REHAB / VR-C-REHAB
- Conditions
- Older Adults (65 Years and Older), Outpatient Treatment, Rehabilitation Frail Elderly Subjects
- Keywords
- municipality-based inpatient rehabilitation care
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Horsholm MunicipalityUniversity, hospital or other
- Study start
- 9 Mar 2026 (actual)
- Primary completion
- 6 Jun 2026 (actual)
- Study completion
- 18 Jun 2026 (actual)
- First posted
- 9 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
VR-C-REHAB is a single-group pilot and feasibility study examining the practicality of implementing virtual-reality-assisted ergometer cycling as an adjunct to usual municipal inpatient rehabilitation for older adults (≥65 years). Many individuals admitted to temporary inpatient care present with low physical activity levels and fluctuating motivation, reducing the achievable exercise dose. Virtual reality may enhance engagement, enjoyment, and adherence, but its feasibility in this setting must be evaluated before conducting a future effect trial.
The primary objective is to determine whether participants can achieve an adequate exercise dose, defined as the proportion of completed VR-cycling sessions out of those offered (target: ≥75%). Secondary feasibility outcomes include recruitment rate, safety and acceptability, and total cycling time. Exploratory outcomes include change in the 10-Meter Walk Test and session-level motivation (0-10). The intervention consists of 15 minutes of VR-assisted cycling, three times weekly for up to four weeks, delivered alongside standard rehabilitation.
Data are collected at baseline, during each session, and at completion. Analyses are descriptive, focusing on the precision of feasibility estimates. Progression criteria (Go/Amend/Stop) are based on adherence, recruitment, and safety. The results will inform the design and implementation of a subsequent controlled study.
Detailed description
Background and Rationale:
Elderly individuals with diminished physical capacity who are admitted to temporary inpatient rehabilitation often exhibit low levels of physical activity and motivation, which can adversely affect the exercise dose during their stay. Cycling is recognized as a safe and effective form of exercise; however, its implementation is often hindered by low commitment and fluctuating daily energy levels.
Virtual reality (VR) has the potential to enhance motivation, perceived enjoyment, and adherence to training by providing distraction, engagement, and a more stimulating exercise environment. Prior to conducting a potential impact study, it is essential to assess the feasibility of recruitment, implementation, acceptance, and exercise dose within municipal inpatient rehabilitation settings.
Objective and Research Question:
Overall Objective:
To investigate the feasibility of a VR-assisted ergometer cycling intervention in conjunction with standard treatment for older adults (aged 65 and above) in rehabilitation during municipality-based inpatient rehabilitation care.
Primary Feasibility Question:
Can participants achieve an adequate exercise dose, as measured by the proportion of completed VR-assisted ergometer cycling sessions out of the total offered sessions, with a feasibility target of ≥75%?
Secondary Feasibility and Exploratory Questions:
What is the recruitment rate (percent proportion of approached individuals who consent to participate)? How does the 10-Meter Walk Test (10 MWT) progress from baseline to completion, reported in m/s? Motivation, Scale 0-10, 10 indicate the highest degree of motivation What is the total duration of cycling (in minutes) completed during the intervention period?
Setting:
Location: Municipality-based inpatient rehabilitation care in the municipality of Hørsholm, managed by the municipal rehabilitation unit.
Regular Treatment: Standard rehabilitation, typically comprising individual and/or group-based training, activities of daily living (ADL) interventions, and mobilization following clinical assessment.
Intervention:
Overview:
Intervention: 15 minutes of cycling with VR goggles in addition to regular treatment.
Frequency: Three times weekly. Duration: Up to 4 weeks (dependent on discharge timing). Delivery: Supervised by physiotherapists or therapeutic staff according to local practices.
Implementation:
Bicycle: Stationary bicycle/ergometer cycle [insert model]. VR Equipment: SyncSense.
Session Structure:
Brief health check (e.g., assessment of tiredness, dizziness, nausea, pain, blood pressure/pulse if relevant) Setup of VR and safe positioning 15 minutes of cycling (pauses permitted) brief conclusion and documentation of any discomfort/side effects.
Dosage and Progression:
The approach is "pragmatic" feasibility, with intensity adjusted to daily energy levels.
The therapist may modify the load (resistance) and pauses to facilitate completion.
Simultaneous Treatment:
Regular rehabilitation continues unchanged and is documented in general terms (e.g., number of therapy contacts per week, if feasible).
Sample Size (Pilot/Feasibility Rationale) A power calculation for the effect will not be conducted. The sample size is determined to estimate feasibility parameters with reasonable precision.
Planned inclusion is N = [12-20] participants. The rationale is to estimate adherence and recruitment rates with confidence intervals and to identify practical implementation barriers.
Recruitment and Consent Screening: Conducted daily/weekly through admission lists/referrals to inpatient care.
Recruitment Procedure:
Involves the identification of potentially suitable individuals Provision of verbal and written information Reflection time in accordance with local guidelines Collection of informed consent A log will cover the number screened, eligible, approached, consented, and causes for dropout/"no".
Statistics and Analysis Plan
General Principle:
The primary descriptive analysis will focus on feasibility estimates and precision, specifically confidence intervals.
No formal hypothesis testing for effect will be conducted; secondary outcomes will be reported in an exploratory manner.
Primary Outcome
Adherence will be reported as follows:
Percent of offered sessions completed. Up to 4 weeks (from baseline to discharge or week 4, whichever occurs first Average (SD) and median (IQR) per participant Collective share of completed/offered sessions for the cohort Recruitment Rate Proportion in percent; Percent consented among approached Causes for non-participation will be categorized. 10MWT and Bicycle Time Change from baseline to finish will be reported as mean change (SD) or median change (IQR).
Visualization: individual spaghetti plots for 10MWT. Lack of Data Feasibility will be assessed by registering the cause of missing measurements (e.g., discharge, illness, logistics).
No imputation will be performed as a general rule; transparency in reporting will be maintained.
Bias and Assurance of Quality Standardized instruction for 10MWT will be provided. Staff will be trained in setting up VR and ensuring safety. Predefined criteria for "offered session" versus "not offered" will be documented, including staff- and illness-related causes.
Injury and Adverse Events All VR-related discomforts (e.g., nausea, dizziness) will be registered. Severe incidents will be reported following local procedures. Stop criteria per session include significant dizziness, nausea, chest pain, acute deterioration, or therapeutic assessment.
Data Management and Security All physical documents, including training records, test results, and the identification key (linking participant IDs to personal information), will be stored in a double-locked cabinet at the primary project site. Access is restricted to authorized project personnel.
Electronic data for statistical analysis will be entered into a secure, encrypted network folder within the municipality's protected IT infrastructure. These datasets will be maintained in an anonymized format, where participants are identified solely by a project-specific ID. No personally identifiable information will appear in the electronic dataset.
The identification key will remain exclusively in paper format and will be stored in the same double-locked cabinet as the physical training and testing data. This key will not be digitized and will only be accessed by the principal investigator or designated personnel for validation or follow-up purposes.
All data handling complies with GDPR regulations and principles for secure management of sensitive personal information. Data will be retained for five years after project completion, after which it will be securely destroyed or archived according to ethical and legal requirements.
The project has been declared to the local ethics committee of the capital region, Denmark, and has received identification number: F-26001623
Communication Results will be reported in accordance with CONSORT pilot/feasibility guidelines, including a flowchart and clear separation between feasibility results and exploratory effect indicators.
Plan: conference abstract and manuscript in a relevant rehabilitation/geriatric journal.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- interventional study with allocation: N/A, masking: none/open label
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: VR cycling |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (4 listed)
- Age ≥65 years
- Referred to rehabilitation during a stay at temporary inpatient care
- Assessed by a therapist as capable of participating in seated cycling (possibly supervised)
- Able to provide informed consent (with relevant support according to local guidelines, if necessary).
Key exclusion criteria (5 listed)
- Medical contraindications to moderate physical activity/cycling (e.g., unstable angina, uncontrolled arrhythmia, acute infection with significant impact)
- Severe dizziness/vestibular symptoms likely to be exacerbated by VR use
- Known photosensitive epilepsy or other conditions posing significant risk with VR stimulation
- Unresolved vision/perception issues or severe nausea rendering VR use unsuitable
- Participation in another intervention study that interferes with this intervention.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VR cycling* Intervention: 15 minutes of cycling with VR goggles in addition to regular treatment. * Frequency: Three times weekly. * Duration: Up to 4 weeks (dependent on discharge timing). * Delivery: Supervised by physiotherapists or therapeutic staff according to local practices. | Other | Intervention |
Primary outcome
Exercise Adherence: In percent
Time frame: 4 weeks (at every exercise session)
Definition: NumbercompletedVR-bicyclessessions/ NumberofferedVR-bicyclesessioner pr. participant, summarised and/or averaged for the entire cohort. The feasibility goal is set at ≥75%. "Offered sessions" are defined as the planned three weekly sessions during the period the participant is admitted and available, excluding days with clearly documented contraindications or acute illness according to predetermined criteria. The reasons for lack of training will be explicitly described in the manual as "illness," covering biological illness or other admitted causes, and "demotivation," which encompasses reasons such as tiredness, demotivation, or discomfort. The actual cause will be described.
4 secondary outcomes
1. Recruitment Rate: Percent
Time frame: Baseline testing (day 0)
walk speed
Time frame: baseline testing and follow up testing after ending the intervention( up to 4 weeks later)
Motivation
Time frame: during every session from enrollment until end of intervention (max 4 weeks)
Total Time Spent Cycling in minutes
Time frame: Week 4 (or after conclusion of the intervention if that happens before)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2026.
- Background: PubMed 38506442Mocco A, Valmaggia L, Bernardi L, Alfieri M, Tarricone I. Enhancing Physical Activity with Immersive Virtual Reality: A Systematic Review. Cyberpsychol Behav Soc Netw. 2024 May;27(5):303-317. doi: 10.1089/cyber.2023.0394. Epub 2024 Mar 20.
- Background: PubMed 40218010Hajder D, Bjelica B, Bubanj S, Aksovic N, Markovic M, Arsenijevic R, Lupu GS, Gasic T, Sufaru C, Toskic L, Dobreci DL, Dobrescu T, Sava MA. A Systematic Review and Meta-Analysis of Virtual and Traditional Physical Activity Programs: Effects on Physical, Health, and Cognitive Outcomes. Healthcare (Basel). 2025 Mar 24;13(7):711. doi: 10.3390/healthcare13070711.
- Background: PubMed 39023808Rytterstrom P, Stromberg A, Jaarsma T, Klompstra L. Exergaming to Increase Physical Activity in Older Adults: Feasibility and Practical Implications. Curr Heart Fail Rep. 2024 Aug;21(4):439-459. doi: 10.1007/s11897-024-00675-9. Epub 2024 Jul 18.
- Background: PubMed 36146092Campo-Prieto P, Cancela-Carral JM, Rodriguez-Fuentes G. Feasibility and Effects of an Immersive Virtual Reality Exergame Program on Physical Functions in Institutionalized Older Adults: A Randomized Clinical Trial. Sensors (Basel). 2022 Sep 6;22(18):6742. doi: 10.3390/s22186742.
- Individual participant dataSharing planned: Yes. Anonymized data on all outcomes will be provided upon request during or after a publication proces.
Related trials for Older Adults (65 Years and Older)
Not yet recruiting
Impact of Pharmacotherapy Optimization in Polymedicated Lebanese Older Adults in Primary Health Care Centers
Older Adults (65 Years and Older), Polypharmacy (People Under Treatment With 5 or More Drugs)
RecruitingPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Recruiting
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
Hip Osteoarthritis
Recruiting
Effects of Breathing Exercises on Cognition in Older Adults
Older Adults (65 Years and Older), Cognition
RecruitingPhase 2
Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game.
Hospital Associated Disability, Immobility
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VR cycling in people with Older Adults (65 Years and Older) and Outpatient Treatment, run by Horsholm Municipality at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise Adherence: In percent (time frame: 4 weeks (at every exercise session)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07459439, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.